Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP477288.RA9b5dhRgf3cjk8oG3Lx3tmZHwi3MPNzLQgyP4HJ0mAHM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP477288.RA9b5dhRgf3cjk8oG3Lx3tmZHwi3MPNzLQgyP4HJ0mAHM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP477288.RA9b5dhRgf3cjk8oG3Lx3tmZHwi3MPNzLQgyP4HJ0mAHM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP477288.RA9b5dhRgf3cjk8oG3Lx3tmZHwi3MPNzLQgyP4HJ0mAHM130_provenance.
- NP477288.RA9b5dhRgf3cjk8oG3Lx3tmZHwi3MPNzLQgyP4HJ0mAHM130_assertion description "[Nine previously untreated patients with Philadelphia chromosome-positive chronic myelocytic leukemia (CML) were treated with recombinant interferon alpha 2a (rIFN-alpha 2a) and hydroxyurea.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP477288.RA9b5dhRgf3cjk8oG3Lx3tmZHwi3MPNzLQgyP4HJ0mAHM130_provenance.
- NP477288.RA9b5dhRgf3cjk8oG3Lx3tmZHwi3MPNzLQgyP4HJ0mAHM130_assertion evidence source_evidence_literature NP477288.RA9b5dhRgf3cjk8oG3Lx3tmZHwi3MPNzLQgyP4HJ0mAHM130_provenance.
- NP477288.RA9b5dhRgf3cjk8oG3Lx3tmZHwi3MPNzLQgyP4HJ0mAHM130_assertion SIO_000772 2736308 NP477288.RA9b5dhRgf3cjk8oG3Lx3tmZHwi3MPNzLQgyP4HJ0mAHM130_provenance.
- NP477288.RA9b5dhRgf3cjk8oG3Lx3tmZHwi3MPNzLQgyP4HJ0mAHM130_assertion wasDerivedFrom befree-20150227 NP477288.RA9b5dhRgf3cjk8oG3Lx3tmZHwi3MPNzLQgyP4HJ0mAHM130_provenance.
- NP477288.RA9b5dhRgf3cjk8oG3Lx3tmZHwi3MPNzLQgyP4HJ0mAHM130_assertion wasGeneratedBy ECO_0000203 NP477288.RA9b5dhRgf3cjk8oG3Lx3tmZHwi3MPNzLQgyP4HJ0mAHM130_provenance.
- befree-20150227 importedOn "2015-02-27" NP477288.RA9b5dhRgf3cjk8oG3Lx3tmZHwi3MPNzLQgyP4HJ0mAHM130_provenance.